Source: MHRA / Gov.uk 20.10.22
hameln pharma ltd is initiating a recall of the affected batches of Ephedrine Hydrochloride 30 mg/ml Solution for Injection as a precautionary measure.
hameln pharma ltd
Ephedrine Hydrochloride 30 mg/ml Solution for Injection, PL 01502/0103
|10 x 1 ml
|10 x 1 ml
Active Pharmaceutical Ingredients: ephedrine hydrochloride
Brief description of the problem
hameln pharma ltd is initiating a recall of the affected batches of Ephedrine Hydrochloride 30 mg/ml Solution for Injection as a precautionary measure. This is due to out of specification results obtained during routine ongoing stability studies, for related substances. Due to the out of specification results observed at higher storage temperatures, ampoules from the affected batches may no longer be in line with the licensed product specification.
Advice for healthcare professionals
Please quarantine any remaining stock of this batch and contact hameln pharma ltd customer services on +44 (0)1452 621 661 or firstname.lastname@example.org to arrange credit for any unused ampoules from this batch.
Advice for patients
Patients are not required to take any action at this time. This product is administered by healthcare professionals directly. If you have concerns about a medicine you may be using, please contact your healthcare professional.
For more information or supply queries, please contact or email hameln pharma ltd customer services on +44 (0)1452 621 661 or email@example.com.
For medical information queries, please contact or email hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or firstname.lastname@example.org.
Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Defective Medicines Report Centre
10 South Colonnade
Telephone +44 (0)20 3080 6574
Click here for the source